The atrial natriuretic peptide- and catecholamine-induced lipolysis and expression of related genes in adipose tissue in hypothyroid and hyperthyroid patients

American Journal of Physiology - Endocrinology and Metabolism

Volumn 293, Issue 1, 2007, Pages

  Polak, J ^a   Moro, C ^a,b,c   Klimcakova, E ^a   Kovacikova, M ^a   Bajzova, M ^a   Vitkova, M ^a   Kovacova, Z ^a   Sotornik, R ^e   Berlan, M ^a,b,c   Viguerie, N ^a,b,c   Langin, D ^a,b,c,d   Stich, V ^a,e  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSERM   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

^d TOULOUSE UNIVERSITY HOSPITAL   (France)

^e CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Adrenergic lipolysis; Gene expression; Thyroid disease

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BETA 2 ADRENERGIC RECEPTOR; CATECHOLAMINE; ISOPRENALINE; LIOTHYRONINE; NATRIURETIC PEPTIDE RECEPTOR TYPE A; PHOSPHODIESTERASE III; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2;

ABDOMINAL SUBCUTANEOUS FAT; ADULT; AGED; ANTHROPOMETRY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENERGY EXPENDITURE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYPERTHYROIDISM; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; LIPOLYSIS; MAJOR CLINICAL STUDY; MALE; MICRODIALYSIS; PRIORITY JOURNAL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ADULT; AGED; ATRIAL NATRIURETIC FACTOR; BODY WEIGHT; CATECHOLAMINES; ENERGY METABOLISM; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; ISOPROTERENOL; LIPOLYSIS; MIDDLE AGED; REGIONAL BLOOD FLOW; SUBCUTANEOUS FAT, ABDOMINAL;

EID: 34547110779     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00688.2006     Document Type: Article

References (30)

1. Arner P, Wennlund A, Ostman J. Regulation of lipolysis by human adipose tissue in hyperthyroidism. J Clin Endocrinol Metab 48: 415-419, 1979.
2. Barbe P, Larrouy D, Boulanger C, Chevillotte E, Viguerie N, Thalamas C, Oliva TM, Roques M, Vidal H, Langin D. Triiodothyronine-mediated up-regulation of UCP2 and UCP3 mRNA expression in human skeletal muscle without coordinated induction of mitochondrial respiratory chain genes. FASEB J 15: 13-15, 2001.
3. Degerman E, Belfrage P, Manganiello VC. Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3). J Biol Chem 272: 6823-6826, 1997.
4. Elks ML, Manganiello VC. Effects of thyroid hormone on regulation of lipolysis and adenosine 3′,5′-monophosphate metabolism in 3T3-L1 adipocytes. Endocrinology 117: 947-953, 1985.
5. Engfeldt P, Arner P, Bolinder J, Wennlund A, Ostman J. Phosphodiesterase activity in human subcutaneous adipose tissue in hyper- and hypothyroidism. J Clin Endocrinol Metab 54: 625-629, 1982.
6. Fellander G, Linde B, Bolinder J. Evaluation of the microdialysis ethanol technique for monitoring of subcutaneous adipose tissue blood flow in humans. Int J Obes Relat Metab Disord 20: 220-226, 1996.
7. Fryer LG, Holness MJ, Sugden MC. Selective modification of insulin action in adipose tissue by hyperthyroidism. J Endocrinol 154: 513-522, 1997.
8. Galitzky J, Sengenes C, Thalamas C, Marques MA, Senard JM, Lafontan M, Berlan M. The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men. J Lipid Res 42: 536-544, 2001.
9. Garg R, Pandey KN. Regulation of guanylyl cyclase/natriuretic peptide receptor-A gene expression. Peptides 26: 1009-1023, 2005.
10. Hellstrom L, Wahrenberg H, Reynisdottir S, Arner P. Catecholamine-induced adipocyte lipolysis in human hyperthyroidism. J Clin Endocrinol Metab 82: 159-166, 1997.
11. Hoffstedt J, Folkesson R, Wahrenberg H, Wennlund A, van Harmelen V, Arner P. A marked upregulation of uncoupling protein 2 gene expression in adipose tissue of hyperthyroid subjects. Horm Metab Res 32: 475-479, 2000.
12. Houben AJ, van der Zander K, de Leeuw PW. Vascular and renal actions of brain natriuretic peptide in man: physiology and pharmacology. Fundam Clin Pharmacol 19: 411-419, 2005.
13. Kern PA, Ranganathan G, Yukht A, Ong JM, Davis RC. Translational regulation of lipoprotein lipase by thyroid hormone is via a cytoplasmic repressor that interacts with the 3′ untranslated region. J Lipid Res 37: 2332-2340, 1996.
14. Krauss S, Zhang CY, Lowell BB. The mitochondrial uncoupling-protein homologues. Nat Rev Mol Cell Biol 6: 248-261, 2005.
15. Lafontan M, Berlan M. Fat cell adrenergic receptors and the control of white and brown fat cell function. J Lipid Res 34: 1057-1091, 1993.
16. Lanni A, Moreno M, Lombardi A, Goglia F. Thyroid hormone and uncoupling proteins. FEBS Lett 543: 5-10, 2003.
17. Large V, Arner P. Regulation of lipolysis in humans. Pathophysiological modulation in obesity, diabetes, and hyperlipidaemia. Diabetes Metab 24: 409-418, 1998.
18. Moro C, Galitzky J, Sengenes C, Crampes F, Lafontan M, Berlan M. Functional and pharmacological characterization of the natriuretic peptide-dependent lipolytic pathway in human fat cells. J Pharmacol Exp Ther 308: 984-992, 2004.
19. Moro C, Pillard F, De Glisezinski I, Harant I, Riviere D, Stich V, Lafontan M, Crampes F, Berlan M. Training enhances ANP lipid-mobilizing action in adipose tissue of overweight men. Med Sci Sports Exerc 37: 1126-1132, 2005.
20. Moro C, Polak J, Richterova B, Sengenes C, Pelikanova T, Galitzky J, Stich V, Lafontan M, Berlan M. Differential regulation of atrial natriuretic peptide- and adrenergic receptor-dependent lipolytic pathways in human adipose tissue. Metabolism 54: 122-131, 2005.
21. Richelsen B, Sorensen NS. Alpha 2- and beta-adrenergic receptor binding and action in gluteal adipocytes from patients with hypothyroidism and hyperthyroidism. Metabolism 36: 1031-1039, 1987.
22. Riis AL, Gravholt CH, Djurhuus CB, Norrelund H, Jorgensen JO, Weeke J, Moller N. Elevated regional lipolysis in hyperthyroidism. J Clin Endocrinol Metab 87: 4747-4753, 2002.
23. Sabrane K, Kruse MN, Fabritz L, Zetsche B, Mitko D, Skryabin BV, Zwiener M, Baba HA, Yanagisawa M, Kuhn M. Vascular endothelium is critically involved in the hypotensive and hypovolemic actions of atrial natriuretic peptide. J Clin Invest 115: 1666-1674, 2005.
24. Sengenes C, Berlan M, De Glisezinski I, Lafontan M, Galitzky J. Natriuretic peptides: a new lipolytic pathway in human adipocytes. FASEB J 14: 1345-1351, 2000.
25. Silva JE. Thyroid hormone control of thermogenesis and energy balance. Thyroid 5: 481-492, 1995.
26. Stich V, Marion-Latard F, Hejnova J, Viguerie N, Lefort C, Suljkovicova H, Langin D, Lafontan M, Berlan M. Hypocaloric diet reduces exercise-induced alpha 2-adrenergic antilipolytic effect and alpha 2-adrenergic receptor mRNA levels in adipose tissue of obese women. J Clin Endocrinol Metab 87: 1274-1281, 2002.
27. Viguerie N, Langin D. Effect of thyroid hormone on gene expression. Curr Opin Clin Nutr Metab Care 6: 377-381, 2003.
28. Viguerie N, Millet L, Avizou S, Vidal H, Larrouy D, Langin D. Regulation of human adipocyte gene expression by thyroid hormone. J Clin Endocrinol Metab 87: 630-634, 2002.
29. Wahrenberg H, Engfeldt P, Arner P, Wennlund A, Ostman J. Adrenergic regulation of lipolysis in human adipocytes: findings in hyper- and hypothyroidism. J Clin Endocrinol Metab 63: 631-638, 1986.
30. Wahrenberg H, Wennlund A, Arner P. Adrenergic regulation of lipolysis in fat cells from hyperthyroid and hypothyroid patients. J Clin Endocrinol Metab 78: 898-903, 1994.